Log In
BCIQ
Print this Print this
 

danirixin (GSK1325756) (formerly 1325756)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCXC chemokine receptor 2 (CXCR2) antagonist
Molecular Target CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today